Literature DB >> 9613040

Superantibody activities: new players in innate and adaptive immune responses.

H Kohler1, S Paul.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9613040     DOI： 10.1016/s0167-5699(97)01234-6

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  7 in total

1.  Some Bence-Jones proteins enter cultured renal tubular cells, reach nuclei and induce cell death.

Authors:  K Matsuura; S Ikoma; M Watanabe; A Togawa; H Sinohara
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.

Authors:  Ankit Mahendra; Ivan Peyron; Olivier Thaunat; Cécile Dollinger; Laurent Gilardin; Meenu Sharma; Bharath Wootla; Desirazu N Rao; Séverine Padiolleau-Lefevre; Didier Boquet; Abhijit More; Navin Varadarajan; Srini V Kaveri; Christophe Legendre; Sébastien Lacroix-Desmazes
Journal:  J Immunol       Date:  2016-04-11       Impact factor: 5.422

3.  Metal-dependent amyloid β-degrading catalytic antibody construct.

Authors:  Yasuhiro Nishiyama; Hiroaki Taguchi; Mariko Hara; Stephanie A Planque; Yukie Mitsuda; Sudhir Paul
Journal:  J Biotechnol       Date:  2014-04-01       Impact factor: 3.307

4.  Physiological IgM class catalytic antibodies selective for transthyretin amyloid.

Authors:  Stephanie A Planque; Yasuhiro Nishiyama; Mariko Hara; Sari Sonoda; Sarah K Murphy; Kenji Watanabe; Yukie Mitsuda; Eric L Brown; Richard J Massey; Stanley R Primmer; Brian O'Nuallain; Sudhir Paul
Journal:  J Biol Chem       Date:  2014-03-19       Impact factor: 5.157

5.  IVIg treatment reduces catalytic antibody titers of renal transplanted patients.

Authors:  Ankit Mahendra; Ivan Peyron; Cécile Dollinger; Laurent Gilardin; Meenu Sharma; Bharath Wootla; Séverine Padiolleau-Lefevre; Alain Friboulet; Didier Boquet; Christophe Legendre; Srinivas V Kaveri; Olivier Thaunat; Sébastien Lacroix-Desmazes
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

Review 6.  Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy.

Authors:  Urai Chaisri; Wanpen Chaicumpa
Journal:  Biomed Res Int       Date:  2018-05-28       Impact factor: 3.411

Review 7.  Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.

Authors:  Kuldeep Dhama; Kumaragurubaran Karthik; Rekha Khandia; Sandip Chakraborty; Ashok Munjal; Shyma K Latheef; Deepak Kumar; Muthannan Andavar Ramakrishnan; Yashpal Singh Malik; Rajendra Singh; Satya Veer Singh Malik; Raj Kumar Singh; Wanpen Chaicumpa
Journal:  Front Immunol       Date:  2018-08-10       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.